Literature DB >> 25319445

Towards indicated prevention of psychosis: using probabilistic assessments of transition risk in psychosis prodrome.

Scott Richard Clark1, Klaus Oliver Schubert, Bernhard Theodor Baune.   

Abstract

The concept of indicated prevention has proliferated in psychiatry, and accumulating evidence suggests that it may indeed be possible to prevent or delay the onset of a first episode of psychosis though adequate interventions in individuals deemed at clinical high risk (CHR) for such an event. One challenge undermining these efforts is the relatively poor predictive accuracy of clinical assessments used in practice for CHR individuals, often leading to diagnostic and therapeutic uncertainty reflected in clinical guidelines promoting a 'watch and wait' approach to CHR patients. Using data from published studies, and employing predictive models based on the odds-ratio form of Bayes' rule, we simulated scenarios where clinical interview, neurocognitive testing, structural magnetic resonance imaging and electrophysiology are part of the initial assessment process of a CHR individual (extended diagnostic approach). Our findings indicate that for most at-risk patients, at least three of these assessments are necessary to arrive at a clinically meaningful differentiation into high- intermediate-, and low-risk groups. In particular, patients with equivocal results in the initial assessments require additional diagnostic testing to produce an accurate risk profile forming part of the comprehensive initial assessment. The findings may inform future research into reliable identification and personalized therapeutic targeting of CHR patients, to prevent transition to full-blown psychosis.

Entities:  

Mesh:

Year:  2014        PMID: 25319445     DOI: 10.1007/s00702-014-1325-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  78 in total

1.  Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.

Authors:  Nikolaos Koutsouleris; Stefan Borgwardt; Eva M Meisenzahl; Ronald Bottlender; Hans-Jürgen Möller; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

Review 2.  The prevention of schizophrenia.

Authors:  A R Yung; E Killackey; S E Hetrick; A G Parker; F Schultze-Lutter; J Klosterkoetter; R Purcell; P D Mcgorry
Journal:  Int Rev Psychiatry       Date:  2007-12

Review 3.  Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders.

Authors:  Richard Banati; Ian B Hickie
Journal:  Med J Aust       Date:  2009-02-16       Impact factor: 7.738

4.  Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Authors:  Danielle A Schlosser; Sarah Jacobson; Qiaolin Chen; Catherine A Sugar; Tara A Niendam; Gang Li; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2011-08-08       Impact factor: 9.306

5.  Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode.

Authors:  Mirjam J van Tricht; Dorien H Nieman; Johannes H T M Koelman; Johan N van der Meer; Lo J Bour; Lieuwe de Haan; Don H Linszen
Journal:  Biol Psychiatry       Date:  2010-10-01       Impact factor: 13.382

6.  Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: prospective follow-up of 245 clinical high-risk outpatients in four countries.

Authors:  Raimo K R Salokangas; Stephan Ruhrmann; Heinrich Graf von Reventlow; Markus Heinimaa; Tanja Svirskis; Tiina From; Sinikka Luutonen; Georg Juckel; Don Linszen; Peter Dingemans; Max Birchwood; Paul Patterson; Frauke Schultze-Lutter; Joachim Klosterkötter
Journal:  Schizophr Res       Date:  2012-03-31       Impact factor: 4.939

7.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

Review 8.  Early intervention in patients at ultra high risk of psychosis: benefits and risks.

Authors:  M B de Koning; O J N Bloemen; T A M J van Amelsvoort; H E Becker; D H Nieman; M van der Gaag; D H Linszen
Journal:  Acta Psychiatr Scand       Date:  2009-03-10       Impact factor: 6.392

9.  Rethinking schizophrenia in the context of normal neurodevelopment.

Authors:  Vibeke S Catts; Samantha J Fung; Leonora E Long; Dipesh Joshi; Ans Vercammen; Katherine M Allen; Stu G Fillman; Debora A Rothmond; Duncan Sinclair; Yash Tiwari; Shan-Yuan Tsai; Thomas W Weickert; Cynthia Shannon Weickert
Journal:  Front Cell Neurosci       Date:  2013-05-15       Impact factor: 5.505

10.  Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

Authors:  P Fusar-Poli; R Smieskova; M J Kempton; B C Ho; N C Andreasen; S Borgwardt
Journal:  Neurosci Biobehav Rev       Date:  2013-06-14       Impact factor: 8.989

View more
  11 in total

1.  Convergence Science Arrives: How Does It Relate to Psychiatry?

Authors:  Harris A Eyre; Helen Lavretsky; Malcolm Forbes; Cyrus Raji; Gary Small; Patrick McGorry; Bernhard T Baune; Charles Reynolds
Journal:  Acad Psychiatry       Date:  2016-03-10

2.  Increased Belief Instability in Psychotic Disorders Predicts Treatment Response to Metacognitive Training.

Authors:  D J Hauke; V Roth; P Karvelis; R A Adams; S Moritz; S Borgwardt; A O Diaconescu; C Andreou
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

Review 3.  Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Authors:  Kristen A Woodberry; Daniel I Shapiro; Caitlin Bryant; Larry J Seidman
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 4.  A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis.

Authors:  Justin Davis; Harris Eyre; Felice N Jacka; Seetal Dodd; Olivia Dean; Sarah McEwen; Monojit Debnath; John McGrath; Michael Maes; Paul Amminger; Patrick D McGorry; Christos Pantelis; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2016-04-09       Impact factor: 8.989

5.  Multimodal prognosis of negative symptom severity in individuals at increased risk of developing psychosis.

Authors:  Daniel J Hauke; André Schmidt; Erich Studerus; Christina Andreou; Anita Riecher-Rössler; Joaquim Radua; Joseph Kambeitz; Anne Ruef; Dominic B Dwyer; Lana Kambeitz-Ilankovic; Theresa Lichtenstein; Rachele Sanfelici; Nora Penzel; Shalaila S Haas; Linda A Antonucci; Paris Alexandros Lalousis; Katharine Chisholm; Frauke Schultze-Lutter; Stephan Ruhrmann; Jarmo Hietala; Paolo Brambilla; Nikolaos Koutsouleris; Eva Meisenzahl; Christos Pantelis; Marlene Rosen; Raimo K R Salokangas; Rachel Upthegrove; Stephen J Wood; Stefan Borgwardt
Journal:  Transl Psychiatry       Date:  2021-05-24       Impact factor: 6.222

6.  Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.

Authors:  S R Clark; B T Baune; K O Schubert; S Lavoie; S Smesny; S M Rice; M R Schäfer; F Benninger; M Feucht; C M Klier; P D McGorry; G P Amminger
Journal:  Transl Psychiatry       Date:  2016-09-20       Impact factor: 6.222

7.  Identifying Electrophysiological Prodromes of Post-traumatic Stress Disorder: Results from a Pilot Study.

Authors:  Chao Wang; Michelle E Costanzo; Paul E Rapp; David Darmon; Kylee Bashirelahi; Dominic E Nathan; Christopher J Cellucci; Michael J Roy; David O Keyser
Journal:  Front Psychiatry       Date:  2017-05-15       Impact factor: 4.157

8.  Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.

Authors:  Rebbekah J Atkinson; W Ross Fulham; Patricia T Michie; Philip B Ward; Juanita Todd; Helen Stain; Robyn Langdon; Renate Thienel; Georgie Paulik; Gavin Cooper; Ulrich Schall
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

9.  Impact of polygenic schizophrenia-related risk and hippocampal volumes on the onset of psychosis.

Authors:  F Harrisberger; R Smieskova; C Vogler; T Egli; A Schmidt; C Lenz; A E Simon; A Riecher-Rössler; A Papassotiropoulos; S Borgwardt
Journal:  Transl Psychiatry       Date:  2016-08-09       Impact factor: 6.222

10.  Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

Authors:  Melanie Föcking; Patrick Dicker; Lorna M Lopez; Mary Cannon; Miriam R Schäfer; Patrick D McGorry; Stefan Smesny; David R Cotter; G Paul Amminger
Journal:  BMC Psychiatry       Date:  2016-09-20       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.